Fluorescein angiography versus optical coherence tomography angiography in macular telangiectasia type i treated with bevacizumab therapy

Nicolas A. Yannuzzi; Ninel Gregori; Luiz Roisman; Nisha Gupta; Brian Goldhagen; Raquel Goldhardt

doi:10.3928/23258160-20170301-12

Fluorescein angiography versus optical coherence tomography angiography in macular telangiectasia type i treated with bevacizumab therapy

Nicolas A. Yannuzzi, Ninel Gregori, Luiz Roisman, Nisha Gupta, Brian Goldhagen, Raquel Goldhardt

Ophthalmology

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

This is a report of microvascular changes seen on fluorescein angiography (FA) and optical coherence tomography angiography (OCTA) in a 47-year-old man with macular telangiectasia Type 1 (MacTel1) after a 7-year bevacizumab (Avastin; Genentech, South San Francisco, CA) treatment course. OCTA allowed for clear visualization of most telangiectasias and aneurysms in the deep capillary plexus, with only few microvascular dilatations in the superficial plexus. In addition, areas of capillary dropout in the superficial and deep vascular plexa located near telangiectasias were documented on OCTA. Serial FA demonstrated reduced number of aneurysms and telangiectasias at the 7-year mark compared to baseline.

Original language	English (US)
Pages (from-to)	263-266
Number of pages	4
Journal	Ophthalmic Surgery Lasers and Imaging Retina
Volume	48
Issue number	3
DOIs	https://doi.org/10.3928/23258160-20170301-12
State	Published - Mar 1 2017

ASJC Scopus subject areas

Surgery
Ophthalmology

Access to Document

10.3928/23258160-20170301-12

Fingerprint Dive into the research topics of 'Fluorescein angiography versus optical coherence tomography angiography in macular telangiectasia type i treated with bevacizumab therapy'. Together they form a unique fingerprint.

Cite this

Fluorescein angiography versus optical coherence tomography angiography in macular telangiectasia type i treated with bevacizumab therapy. / Yannuzzi, Nicolas A.; Gregori, Ninel; Roisman, Luiz; Gupta, Nisha; Goldhagen, Brian ; Goldhardt, Raquel.

In: Ophthalmic Surgery Lasers and Imaging Retina, Vol. 48, No. 3, 01.03.2017, p. 263-266.

Research output: Contribution to journal › Article › peer-review

@article{11bbb54f8ab44c2e8bc74cbfc8ea2068,

title = "Fluorescein angiography versus optical coherence tomography angiography in macular telangiectasia type i treated with bevacizumab therapy",

abstract = "This is a report of microvascular changes seen on fluorescein angiography (FA) and optical coherence tomography angiography (OCTA) in a 47-year-old man with macular telangiectasia Type 1 (MacTel1) after a 7-year bevacizumab (Avastin; Genentech, South San Francisco, CA) treatment course. OCTA allowed for clear visualization of most telangiectasias and aneurysms in the deep capillary plexus, with only few microvascular dilatations in the superficial plexus. In addition, areas of capillary dropout in the superficial and deep vascular plexa located near telangiectasias were documented on OCTA. Serial FA demonstrated reduced number of aneurysms and telangiectasias at the 7-year mark compared to baseline.",

author = "Yannuzzi, {Nicolas A.} and Ninel Gregori and Luiz Roisman and Nisha Gupta and Brian Goldhagen and Raquel Goldhardt",

year = "2017",

month = mar,

day = "1",

doi = "10.3928/23258160-20170301-12",

language = "English (US)",

volume = "48",

pages = "263--266",

journal = "Ophthalmic Surgery Lasers and Imaging Retina",

issn = "2325-8160",

publisher = "Slack Incorporated",

number = "3",

}

TY - JOUR

T1 - Fluorescein angiography versus optical coherence tomography angiography in macular telangiectasia type i treated with bevacizumab therapy

AU - Yannuzzi, Nicolas A.

AU - Gregori, Ninel

AU - Roisman, Luiz

AU - Gupta, Nisha

AU - Goldhagen, Brian

AU - Goldhardt, Raquel

PY - 2017/3/1

Y1 - 2017/3/1

N2 - This is a report of microvascular changes seen on fluorescein angiography (FA) and optical coherence tomography angiography (OCTA) in a 47-year-old man with macular telangiectasia Type 1 (MacTel1) after a 7-year bevacizumab (Avastin; Genentech, South San Francisco, CA) treatment course. OCTA allowed for clear visualization of most telangiectasias and aneurysms in the deep capillary plexus, with only few microvascular dilatations in the superficial plexus. In addition, areas of capillary dropout in the superficial and deep vascular plexa located near telangiectasias were documented on OCTA. Serial FA demonstrated reduced number of aneurysms and telangiectasias at the 7-year mark compared to baseline.

AB - This is a report of microvascular changes seen on fluorescein angiography (FA) and optical coherence tomography angiography (OCTA) in a 47-year-old man with macular telangiectasia Type 1 (MacTel1) after a 7-year bevacizumab (Avastin; Genentech, South San Francisco, CA) treatment course. OCTA allowed for clear visualization of most telangiectasias and aneurysms in the deep capillary plexus, with only few microvascular dilatations in the superficial plexus. In addition, areas of capillary dropout in the superficial and deep vascular plexa located near telangiectasias were documented on OCTA. Serial FA demonstrated reduced number of aneurysms and telangiectasias at the 7-year mark compared to baseline.

UR - http://www.scopus.com/inward/record.url?scp=85016953602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016953602&partnerID=8YFLogxK

U2 - 10.3928/23258160-20170301-12

DO - 10.3928/23258160-20170301-12

M3 - Article

C2 - 28297041

AN - SCOPUS:85016953602

VL - 48

SP - 263

EP - 266

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

IS - 3

ER -